Medgend Icon







discontinued


Carbidopa FDA Approved Drugs

CARBIDOPA [CarbidopaC10H14N2O4H2O]
RX
-
25mg (oral tablet)
Alvogen MaltaJan 8, 2016
Amerigen Pharms LtdMar 10, 2014
Edenbridge PharmsFeb 17, 2016
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CARBIDOPA AND LEVODOPA [CarbidopaC10H14N2O4H2O : LevodopaC9H11NO4]
RX
-
10mg : 100mg (oral tablet)
25mg : 100mg (oral tablet, extended release)
25mg : 250mg (oral tablet)
50mg : 200mg (oral tablet, extended release)
Actavis ElizabethSep 3, 1993
Apotex IncJun 2, 2008
Mayne PharmaAug 28, 1992
MylanSep 18, 2008
Sun Pharm IndsOct 28, 2008
Sun Pharma GlobalJul 31, 2009
Accord HlthcareFeb 8, 2013
Impax LabsMay 14, 2004
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CARBIDOPA, LEVODOPA AND ENTACAPONE [CarbidopaC10H14N2O4H2O : EntacaponeC14H15N3O5 : LevodopaC9H11NO4]
RX
-
12.5mg : 200mg : 50mg (oral tablet)
18.75mg : 200mg : 75mg (oral tablet)
25mg : 200mg : 100mg (oral tablet)
31.25mg : 200mg : 125mg (oral tablet)
37.5mg : 200mg : 150mg (oral tablet)
50mg : 200mg : 200mg (oral tablet)
Wockhardt LtdNov 20, 2012
Sun Pharma GlobalMay 10, 2012
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DUOPA [CarbidopaC10H14N2O4H2O : LevodopaC9H11NO4]
RX
-
4.63mg/ml : 20mg/ml (enteral suspension)
Abbvie IncJan 9, 2015
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LODOSYN [CarbidopaC10H14N2O4H2O]
RX
-
25mg (oral tablet)
AtonApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

RYTARY [CarbidopaC10H14N2O4H2O : LevodopaC9H11NO4]
RX
-
23.75mg : 95mg (oral capsule, extended release)
36.25mg : 145mg (oral capsule, extended release)
48.75mg : 195mg (oral capsule, extended release)
61.25mg : 245mg (oral capsule, extended release)
Impax Labs IncJan 7, 2015
  • Method of providing a therapeutically effective and stable median blood plasma level of levodopa.
  • Treatment of parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
  • Treatment of parkinson's disease.
  • Treatment of parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
  • Treatment of post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
  • Treatment of post-encephalitic parkinsonism.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

SINEMET [CarbidopaC10H14N2O4H2O : LevodopaC9H11NO4]
RX
-
10mg : 100mg (oral tablet)
25mg : 100mg (oral tablet)
25mg : 250mg (oral tablet)
Merck Sharp DohmeApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

SINEMET CR [CarbidopaC10H14N2O4H2O : LevodopaC9H11NO4]
RX
-
25mg : 100mg (oral tablet, extended release)
50mg : 200mg (oral tablet, extended release)
Merck Sharp DohmeDec 24, 1992
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

STALEVO 100 [CarbidopaC10H14N2O4H2O : EntacaponeC14H15N3O5 : LevodopaC9H11NO4]
RX
-
25mg : 200mg : 100mg (oral tablet)
Orion PharmaJun 11, 2003
  • Treatment of parkinson's disease.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

STALEVO 125 [CarbidopaC10H14N2O4H2O : EntacaponeC14H15N3O5 : LevodopaC9H11NO4]
RX
-
31.25mg : 200mg : 125mg (oral tablet)
Orion PharmaAug 29, 2008
  • Treatment of parkinson's disease.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

STALEVO 150 [CarbidopaC10H14N2O4H2O : EntacaponeC14H15N3O5 : LevodopaC9H11NO4]
RX
-
37.5mg : 200mg : 150mg (oral tablet)
Orion PharmaJun 11, 2003
  • Treatment of parkinson's disease.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

STALEVO 200 [CarbidopaC10H14N2O4H2O : EntacaponeC14H15N3O5 : LevodopaC9H11NO4]
RX
-
50mg : 200mg : 200mg (oral tablet)
Orion PharmaAug 2, 2007
  • Treatment of parkinson's disease.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

STALEVO 50 [CarbidopaC10H14N2O4H2O : EntacaponeC14H15N3O5 : LevodopaC9H11NO4]
RX
-
12.5mg : 200mg : 50mg (oral tablet)
Orion PharmaJun 11, 2003
  • Treatment of parkinson's disease.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

STALEVO 75 [CarbidopaC10H14N2O4H2O : EntacaponeC14H15N3O5 : LevodopaC9H11NO4]
RX
-
18.75mg : 200mg : 75mg (oral tablet)
Orion PharmaAug 29, 2008
  • Treatment of parkinson's disease.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

XADAGO [Safinamide MesylateC17H19FN2O2CH4O3S]
RX
-
100mg (oral tablet)
50mg (oral tablet)
Us Worldmeds LlcMar 21, 2017
  • Adjunctive treatment to levodopa/carbidopa in patients with parkinson's disease experiencing 'off' episodes.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.